The therapeutic efficacy of amantadine can be decreased when used in combination with Blonanserin.


The therapeutic efficacy of gliclazide can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of nitrendipine can be decreased when used in combination with calcium lactate.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with tolmetin.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of prazosin can be decreased when used in combination with acemetacin.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with resveratrol.


The therapeutic efficacy of metformin can be decreased when used in combination with Atazanavir.


The therapeutic efficacy of polythiazide can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of latanoprost can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of Terlipressin can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with Fluprednidene.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with histrelin.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with Magnesium trisilicate.


The therapeutic efficacy of Travoprost can be decreased when used in combination with aspirin.


The therapeutic efficacy of polythiazide can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of losartan can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Rotigotine can be decreased when used in combination with Pimavanserin.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Octreotide.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with polythiazide.


The therapeutic efficacy of Miglustat can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of mesoridazine can be decreased when used in combination with levodopa.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of glimepiride can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with TICARCILLIN.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with diclofenac.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with Isoconazole.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of glimepiride can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of betahistine can be decreased when used in combination with famotidine.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with halcinonide.


The therapeutic efficacy of liothyronine can be decreased when used in combination with estrone.


The therapeutic efficacy of gemeprost can be decreased when used in combination with floctafenine.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with nisoldipine.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with paramethasone.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with secobarbital.


The therapeutic efficacy of pancuronium can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of penicillin g can be decreased when used in combination with minocycline.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with prednisone.


The therapeutic efficacy of Vecuronium can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of PIPECURONIUM can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of nateglinide can be decreased when used in combination with goserelin.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of MEZLOCILLIN can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Liotrix can be decreased when used in combination with dienestrol.


The therapeutic efficacy of ursodiol can be decreased when used in combination with dienestrol.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of acarbose can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of bisacodyl can be decreased when used in combination with MAGNESIUM HYDROXIDE.


The therapeutic efficacy of polythiazide can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with Alitretinoin.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with QUINESTROL.


The therapeutic efficacy of ursodiol can be decreased when used in combination with Etofibrate.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of Gatate can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of Limaprost can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of apomorphine can be decreased when used in combination with Perospirone.


The therapeutic efficacy of calcitriol can be decreased when used in combination with BECLOMETHASONE DIPROPIONATE.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of MOLINDONE can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of glyburide can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Propiverine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of nitrazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Bismuth subcitrate potassium can be decreased when used in combination with SODIUM BICARBONATE.


The therapeutic efficacy of latanoprost can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with diazoxide.


The therapeutic efficacy of nateglinide can be decreased when used in combination with metolazone.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with ambenonium.


The therapeutic efficacy of glimepiride can be decreased when used in combination with metolazone.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Articaine.


The therapeutic efficacy of acarbose can be decreased when used in combination with Darunavir.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of EDOXABAN can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of CYCLACILLIN can be decreased when used in combination with minocycline.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of nateglinide can be decreased when used in combination with histrelin.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of PAMIDRONIC ACID can be decreased when used in combination with rabeprazole.


The therapeutic efficacy of calcitriol can be decreased when used in combination with medrysone.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with prednisone.


The therapeutic efficacy of REMIFENTANIL can be decreased when used in combination with naltrexone.


The therapeutic efficacy of tolterodine can be decreased when used in combination with decamethonium.


The therapeutic efficacy of hyoscyamine can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with famotidine.


The therapeutic efficacy of latanoprost can be decreased when used in combination with nimesulide.


The therapeutic efficacy of indapamide can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of nateglinide can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of Apixaban can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cefamandole.


The therapeutic efficacy of tolterodine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of phenobarbital can be decreased when used in combination with mianserin.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with danazol.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of polythiazide can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with FLUTICASONE PROPIONATE.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of Miglustat can be decreased when used in combination with rapamycin.


The therapeutic efficacy of misoprostol can be decreased when used in combination with fenbufen.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with indomethacin.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with rapamycin.


The therapeutic efficacy of chlorprothixene can be decreased when used in combination with apomorphine.


The therapeutic efficacy of PHENPROCOUMON can be decreased when used in combination with norethindrone.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with prednisone.


The therapeutic efficacy of PENTAERYTHRITOL TETRANITRATE can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of EDTA can be decreased when used in combination with progesterone.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with galanthamine.


The therapeutic efficacy of Delorazepam can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Metixene can be decreased when used in combination with physostigmine.


The therapeutic efficacy of ACENOCOUMAROL can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with etodolac.


The therapeutic efficacy of estazolam can be decreased when used in combination with theophylline.


The therapeutic efficacy of Tramadol can be decreased when used in combination with promazine.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of diazoxide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with norethindrone.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with acemetacin.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Cilastatin.


The therapeutic efficacy of glipizide can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with DEFLAZACORT.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with CLOCORTOLONE.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of voglibose can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with Dienogest.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with phenobarbital.


The therapeutic efficacy of alprenolol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of promazine can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of dorzolamide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of estradiol can be decreased when used in combination with Alitretinoin.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of benztropine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of glyburide can be decreased when used in combination with ritonavir.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of alprostadil can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of betahistine can be decreased when used in combination with ketotifen.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Apremilast.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with nabumetone.


The therapeutic efficacy of barnidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of acarbose can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with diazoxide.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of voglibose can be decreased when used in combination with diazoxide.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with pentobarbital.


The therapeutic efficacy of oxybutynin can be decreased when used in combination with donepezil.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with olanzapine.


The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with DESONIDE.


The therapeutic efficacy of ethinyl estradiol can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of methenamine can be decreased when used in combination with Aluminium hydroxide.


The therapeutic efficacy of acemetacin can be decreased when used in combination with droxidopa.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Estrone sulfate.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with salicylamide.


The therapeutic efficacy of polythiazide can be decreased when used in combination with sulindac.


The therapeutic efficacy of Aclidinium can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of ANISOTROPINE METHYLBROMIDE can be decreased when used in combination with galanthamine.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with estriol.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of polythiazide can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with FLUOCORTOLONE.


The therapeutic efficacy of misoprostol can be decreased when used in combination with diflunisal.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with polythiazide.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with thalidomide.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with loteprednol.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of Propiverine can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of mesalamine can be decreased when used in combination with Bismuth subcitrate potassium.


The therapeutic efficacy of prochlorperazine can be decreased when used in combination with levodopa.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of Travoprost can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with SAQUINAVIR.


The therapeutic efficacy of Aliskiren can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of dienestrol can be decreased when used in combination with Alitretinoin.


The therapeutic efficacy of gemeprost can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of flurazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Asenapine.


The therapeutic efficacy of indapamide can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of ropinirole can be decreased when used in combination with Cariprazine.


The therapeutic efficacy of Coenzyme Q10 can be decreased when used in combination with propranolol.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with DESONIDE.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with loxapine.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with phenytoin.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with epirizole.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with alclofenac.


The therapeutic efficacy of metolazone can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of Fondaparinux can be decreased when used in combination with progesterone.


The therapeutic efficacy of nateglinide can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with polythiazide.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of indapamide can be decreased when used in combination with carprofen.


The therapeutic efficacy of gliclazide can be decreased when used in combination with prednisone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with resveratrol.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with citalopram.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Naftifine.


The therapeutic efficacy of MOXONIDINE can be decreased when used in combination with Tianeptine.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of HYDROCODONE can be decreased when used in combination with naltrexone.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with risperidone.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with azelastine.


The therapeutic efficacy of polythiazide can be decreased when used in combination with azelastine.


The therapeutic efficacy of Tramadol can be decreased when used in combination with Cobicistat.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with theophylline.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with epinephrine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of nateglinide can be decreased when used in combination with betamethasone.


The therapeutic efficacy of glimepiride can be decreased when used in combination with mestranol.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with physostigmine.


The therapeutic efficacy of glyburide can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with azelastine.


The therapeutic efficacy of piperacillin can be decreased when used in combination with minocycline.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of Metixene can be decreased when used in combination with mefloquine.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with Fluprednidene.


The therapeutic efficacy of Mometasone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Desloratadine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of scopolamine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of latanoprost can be decreased when used in combination with nabumetone.


The therapeutic efficacy of acemetacin can be decreased when used in combination with clenbuterol.


The therapeutic efficacy of glimepiride can be decreased when used in combination with histrelin.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with FLUPHENAZINE.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with resveratrol.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of calcitriol can be decreased when used in combination with CLOBETASOL PROPIONATE.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Icatibant.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with malathion.


The therapeutic efficacy of glipizide can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of metformin can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with VALPROIC ACID.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of latanoprost can be decreased when used in combination with acemetacin.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with loteprednol.


The therapeutic efficacy of estradiol can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of polythiazide can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with bumetanide.


The therapeutic efficacy of metformin can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of Tramadol can be decreased when used in combination with haloperidol.


The therapeutic efficacy of Bivalirudin can be decreased when used in combination with norethindrone.


The therapeutic efficacy of metolazone can be decreased when used in combination with diflunisal.


The therapeutic efficacy of anastrozole can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with norethindrone.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of Aclidinium can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of glyburide can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of voglibose can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of Limaprost can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of carbamazepine can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with secobarbital.


The therapeutic efficacy of Miglustat can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with nabumetone.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with itraconazole.


The therapeutic efficacy of betahistine can be decreased when used in combination with Chloropyramine.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with malathion.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with memantine.


The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with naltrexone.


The therapeutic efficacy of codeine can be decreased when used in combination with Vitamin D3.


The therapeutic efficacy of gemeprost can be decreased when used in combination with celecoxib.


The therapeutic efficacy of flunarizine can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of metolazone can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of polythiazide can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of ipratropium can be decreased when used in combination with Demecarium.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Torasemide.


The therapeutic efficacy of periciazine can be decreased when used in combination with levodopa.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Salsalate.


The therapeutic efficacy of indapamide can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of EDTA can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of glipizide can be decreased when used in combination with Torasemide.


The therapeutic efficacy of Propiverine can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with cilazapril.


The therapeutic efficacy of ipratropium can be decreased when used in combination with decamethonium.


The therapeutic efficacy of Apixaban can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of gemeprost can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of acemetacin can be decreased when used in combination with Salmeterol.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of nifedipine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of glipizide can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of oxyphenonium can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Lormetazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Darunavir.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of latanoprost can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Tramadol can be decreased when used in combination with clozapine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with fenbufen.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with DEFLAZACORT.


The therapeutic efficacy of gemeprost can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with amobarbital.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with furosemide.


The therapeutic efficacy of EXEMESTANE can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with CEFPODOXIME.


The therapeutic efficacy of tubocurarine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with D-cycloserine.


The therapeutic efficacy of gemeprost can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of Travoprost can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of Propiverine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of glyburide can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of nisoldipine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with olanzapine.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with decamethonium.


The therapeutic efficacy of betahistine can be decreased when used in combination with Pemirolast.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of diazepam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of chlorprothixene can be decreased when used in combination with amantadine.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of Captodiame can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with mefloquine.


The therapeutic efficacy of metformin can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with fenbufen.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with ketorolac.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with diflunisal.


The therapeutic efficacy of Liotrix can be decreased when used in combination with venlafaxine.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of eperisone can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Apremilast.


The therapeutic efficacy of citric acid can be decreased when used in combination with dydrogesterone.


The therapeutic efficacy of nateglinide can be decreased when used in combination with progesterone.


The therapeutic efficacy of glimepiride can be decreased when used in combination with progesterone.


The therapeutic efficacy of biperiden can be decreased when used in combination with physostigmine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with floctafenine.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Naftifine.


The therapeutic efficacy of Radioiodine can be decreased when used in combination with liothyronine.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of gabapentin can be decreased when used in combination with mianserin.


The therapeutic efficacy of misoprostol can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Fosamprenavir.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with miconazole.


The therapeutic efficacy of loxapine can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of levodopa can be decreased when used in combination with isoniazid.


The therapeutic efficacy of levodopa can be decreased when used in combination with SERTINDOLE.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with diclofenac.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Articaine.


The therapeutic efficacy of ethinyl estradiol can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of folic acid can be decreased when used in combination with Droxicam.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with diflunisal.


The therapeutic efficacy of fludiazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with salicylamide.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of clorazepate can be decreased when used in combination with mefloquine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of calcitriol can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of mesalamine can be decreased when used in combination with olanzapine.


The therapeutic efficacy of 5-Fluorocytosine can be decreased when used in combination with cytarabine.


The therapeutic efficacy of vigabatrin can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with memantine.


The therapeutic efficacy of GUANADREL can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with thiothixene.


The therapeutic efficacy of metolazone can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with galanthamine.


The therapeutic efficacy of amantadine can be decreased when used in combination with MELPERONE.


The therapeutic efficacy of polythiazide can be decreased when used in combination with antipyrine.


The therapeutic efficacy of acarbose can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with SERTINDOLE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with mesalamine.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of latanoprost can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of glyburide can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with primidone.


The therapeutic efficacy of biperiden can be decreased when used in combination with ambenonium.


The therapeutic efficacy of NICORANDIL can be decreased when used in combination with acemetacin.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with trimetrexate.


The therapeutic efficacy of acarbose can be decreased when used in combination with Octreotide.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Remikiren.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of Liotrix can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with diflunisal.


The therapeutic efficacy of flurazepam can be decreased when used in combination with aminophylline.


The therapeutic efficacy of polythiazide can be decreased when used in combination with suprofen.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with suprofen.


The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with GESTODENE.


The therapeutic efficacy of dienestrol can be decreased when used in combination with amobarbital.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with ketorolac.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of Fondaparinux can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of acarbose can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with thiopental.


The therapeutic efficacy of ethopropazine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of alprostadil can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with estrone.


The therapeutic efficacy of benztropine can be decreased when used in combination with memantine.


The therapeutic efficacy of eperisone can be decreased when used in combination with mianserin.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of voglibose can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with captopril.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with risperidone.


The therapeutic efficacy of tolazamide can be decreased when used in combination with estradiol.


The therapeutic efficacy of hyoscyamine can be decreased when used in combination with memantine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with MEPHENTERMINE.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with galanthamine.


The therapeutic efficacy of triazolam can be decreased when used in combination with theophylline.


The therapeutic efficacy of latanoprost can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of metolazone can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Naftifine.


The therapeutic efficacy of Clevidipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of FLUPHENAZINE can be decreased when used in combination with amantadine.


The therapeutic efficacy of Liotrix can be decreased when used in combination with fluoxetine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with ERGOTAMINE.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of methenamine can be decreased when used in combination with Aluminium.


The therapeutic efficacy of alprostadil can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of tolterodine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of metformin can be decreased when used in combination with estradiol.


The therapeutic efficacy of codeine can be decreased when used in combination with cocaine.


The therapeutic efficacy of EDOXABAN can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with betamethasone.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with ketorolac.


The therapeutic efficacy of glimepiride can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with alclofenac.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with danazol.


The therapeutic efficacy of Miglustat can be decreased when used in combination with metolazone.


The therapeutic efficacy of Limaprost can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of voglibose can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of physostigmine can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of rivastigmine can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with Esomeprazole.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with azelastine.


The therapeutic efficacy of latanoprost can be decreased when used in combination with aspirin.


The therapeutic efficacy of Limaprost can be decreased when used in combination with diflunisal.


The therapeutic efficacy of biperiden can be decreased when used in combination with mefloquine.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with Dehydroepiandrosterone.


The therapeutic efficacy of acetazolamide can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Tramadol can be decreased when used in combination with ropinirole.


The therapeutic efficacy of Torasemide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with loteprednol.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with carprofen.


The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with omeprazole.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with prednisone.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Darunavir.


The therapeutic efficacy of amantadine can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with chloroquine.


The therapeutic efficacy of formoterol can be decreased when used in combination with betahistine.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with histrelin.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of calcitriol can be decreased when used in combination with diflorasone.


The therapeutic efficacy of latanoprost can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with NATAMYCIN.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with indinavir.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with mefloquine.


The therapeutic efficacy of folic acid can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with acemetacin.


The therapeutic efficacy of PENTAERYTHRITOL TETRANITRATE can be decreased when used in combination with progesterone.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Apremilast.


The therapeutic efficacy of gliclazide can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of gemeprost can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with diazoxide.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with chloroquine.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of dienestrol can be decreased when used in combination with secobarbital.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with acemetacin.


The therapeutic efficacy of hyoscyamine can be decreased when used in combination with decamethonium.


The therapeutic efficacy of metolazone can be decreased when used in combination with Droxicam.


The therapeutic efficacy of Travoprost can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of Travoprost can be decreased when used in combination with sulindac.


The therapeutic efficacy of levodopa can be decreased when used in combination with MELPERONE.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Torasemide.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with memantine.


The therapeutic efficacy of PHENPROCOUMON can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with diclofenac.


The therapeutic efficacy of CYCLACILLIN can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of FLUPHENAZINE can be decreased when used in combination with levodopa.


The therapeutic efficacy of thiothixene can be decreased when used in combination with levodopa.


The therapeutic efficacy of Thioproperazine can be decreased when used in combination with levodopa.


The therapeutic efficacy of Zuclopenthixol can be decreased when used in combination with levodopa.


The therapeutic efficacy of metformin can be decreased when used in combination with Pipotiazine.


The therapeutic efficacy of betahistine can be decreased when used in combination with Desloratadine.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of acarbose can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of OXCARBAZEPINE can be decreased when used in combination with mianserin.


The therapeutic efficacy of Trospium can be decreased when used in combination with malathion.


The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of metolazone can be decreased when used in combination with tolmetin.


The therapeutic efficacy of estazolam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of Clodronic Acid can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of Miglustat can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of glyburide can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of clotiazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of bromazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with epirizole.


The therapeutic efficacy of propantheline can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of indapamide can be decreased when used in combination with floctafenine.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with Cyamemazine.


The therapeutic efficacy of prochlorperazine can be decreased when used in combination with amantadine.


The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with mesalamine.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with GESTODENE.


The therapeutic efficacy of nisoldipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of ethinyl estradiol can be decreased when used in combination with amobarbital.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of diltiazem can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of mesalamine can be decreased when used in combination with rabeprazole.


The therapeutic efficacy of misoprostol can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with SIMEPREVIR.


The therapeutic efficacy of acarbose can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with Almasilate.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of argatroban can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Tigecycline.


The therapeutic efficacy of Clodronic Acid can be decreased when used in combination with pantoprazole.


The therapeutic efficacy of apomorphine can be decreased when used in combination with clozapine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with imipenem.


The therapeutic efficacy of Roflumilast can be decreased when used in combination with amoxapine.


The therapeutic efficacy of Gatate can be decreased when used in combination with SOMATOSTATIN.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with metolazone.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with diclofenac.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of indapamide can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of anastrozole can be decreased when used in combination with estradiol.


The therapeutic efficacy of levorphanol can be decreased when used in combination with naltrexone.


The therapeutic efficacy of norgestrel can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of Limaprost can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of Trospium can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of metolazone can be decreased when used in combination with antipyrine.


The therapeutic efficacy of voglibose can be decreased when used in combination with Dabrafenib.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Dabrafenib.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Sitagliptin.


The therapeutic efficacy of meprobamate can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Naftifine.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with medrysone.


The therapeutic efficacy of Apixaban can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of glyburide can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with Mephobarbital.


The therapeutic efficacy of Liotrix can be decreased when used in combination with tibolone.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of biperiden can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with norethindrone.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Torasemide.


The therapeutic efficacy of flunitrazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of tofisopam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of ursodiol can be decreased when used in combination with clofibrate.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of acarbose can be decreased when used in combination with prednisone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of 11C-choline chloride can be decreased when used in combination with flutamide.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Atazanavir.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of flurazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of argatroban can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with formestane.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Naftifine.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of reserpine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of metformin can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of methenamine can be decreased when used in combination with Trometamol.


The therapeutic efficacy of gliclazide can be decreased when used in combination with polythiazide.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with polythiazide.


The therapeutic efficacy of Dienogest can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of codeine can be decreased when used in combination with Cinacalcet.


The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with diclofenac.


The therapeutic efficacy of Norelgestromin can be decreased when used in combination with primidone.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with sulfanilamide.


The therapeutic efficacy of voglibose can be decreased when used in combination with betamethasone.


The therapeutic efficacy of tolazamide can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with betamethasone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with bumetanide.


The therapeutic efficacy of mestranol can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of gemeprost can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with Escitalopram.


The therapeutic efficacy of gemeprost can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with ceritinib.


The therapeutic efficacy of norgestrel can be decreased when used in combination with primidone.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of acarbose can be decreased when used in combination with Dienogest.


The therapeutic efficacy of gliclazide can be decreased when used in combination with clozapine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with risperidone.


The therapeutic efficacy of metolazone can be decreased when used in combination with alclofenac.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with malathion.


The therapeutic efficacy of metolazone can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of biperiden can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with tolmetin.


The therapeutic efficacy of ADINAZOLAM can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of norgestrel can be decreased when used in combination with tretinoin.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with malathion.


The therapeutic efficacy of estradiol can be decreased when used in combination with METHOHEXITAL.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with amcinonide.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with prednisone.


The therapeutic efficacy of nateglinide can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of ANISOTROPINE METHYLBROMIDE can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with bumetanide.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with ketorolac.


The therapeutic efficacy of Travoprost can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of Miglustat can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of polythiazide can be decreased when used in combination with indomethacin.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of Limaprost can be decreased when used in combination with ketorolac.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with physostigmine.


The therapeutic efficacy of Radioiodine can be decreased when used in combination with Liotrix.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of ursodiol can be decreased when used in combination with QUINESTROL.


The therapeutic efficacy of Liotrix can be decreased when used in combination with QUINESTROL.


The therapeutic efficacy of nateglinide can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with epirizole.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with Demecarium.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with rapamycin.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with etodolac.


The therapeutic efficacy of metolazone can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of liothyronine can be decreased when used in combination with fluvoxamine.


The therapeutic efficacy of Gestrinone can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of voglibose can be decreased when used in combination with rapamycin.


The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of phenacemide can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with ketorolac.


The therapeutic efficacy of indapamide can be decreased when used in combination with leflunomide.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of Progabide can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Phensuximide can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with edrophonium.


The therapeutic efficacy of tubocurarine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Salsalate.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with prednisone.


The therapeutic efficacy of phenoxybenzamine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with acemetacin.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of misoprostol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of propantheline can be decreased when used in combination with donepezil.


The therapeutic efficacy of naphazoline can be decreased when used in combination with mianserin.


The therapeutic efficacy of DESMOPRESSIN can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with amitriptyline.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with PREDNICARBATE.


The therapeutic efficacy of Pregabalin can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of norgestrel can be decreased when used in combination with Acitretin.


The therapeutic efficacy of voglibose can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of MEGESTROL ACETATE can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of gliclazide can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of tolazamide can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of ipratropium can be decreased when used in combination with amoxapine.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with indomethacin.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with indapamide.


The therapeutic efficacy of diazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Levomepromazine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of barnidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Limaprost can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with azelastine.


The therapeutic efficacy of ETONOGESTREL can be decreased when used in combination with Acitretin.


The therapeutic efficacy of PAMIDRONIC ACID can be decreased when used in combination with pantoprazole.


The therapeutic efficacy of alprostadil can be decreased when used in combination with azelastine.


The therapeutic efficacy of latanoprost can be decreased when used in combination with ketorolac.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cefadroxil.


The therapeutic efficacy of Apixaban can be decreased when used in combination with progesterone.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of ETONOGESTREL can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with risperidone.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of voglibose can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Dienogest.


The therapeutic efficacy of Limaprost can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of cilazapril can be decreased when used in combination with acemetacin.


The therapeutic efficacy of potassium ion can be decreased when used in combination with acemetacin.


The therapeutic efficacy of calcitriol can be decreased when used in combination with equilin.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with diflorasone.


The therapeutic efficacy of Spirapril can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of phentolamine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with estradiol.


The therapeutic efficacy of MOEXIPRIL can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Articaine.


The therapeutic efficacy of folic acid can be decreased when used in combination with sulindac.


The therapeutic efficacy of dienestrol can be decreased when used in combination with Acitretin.


The therapeutic efficacy of Liotrix can be decreased when used in combination with Milnacipran.


The therapeutic efficacy of tolazamide can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with duloxetine.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of DESONIDE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of etizolam can be decreased when used in combination with theophylline.


The therapeutic efficacy of anastrozole can be decreased when used in combination with estrone.


The therapeutic efficacy of Travoprost can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with dydrogesterone.


The therapeutic efficacy of apomorphine can be decreased when used in combination with mianserin.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with indapamide.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Miglustat can be decreased when used in combination with indapamide.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Ximelagatran.


The therapeutic efficacy of epinephrine can be decreased when used in combination with betahistine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cefotiam.


The therapeutic efficacy of Dienogest can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of celiprolol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Debrisoquine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Dexrazoxane can be decreased when used in combination with dimethyl sulfoxide.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Torasemide.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of nateglinide can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Norelgestromin can be decreased when used in combination with tretinoin.


The therapeutic efficacy of propantheline can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with ROLITETRACYCLINE.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with fluoxetine.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of warfarin can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with ambenonium.


The therapeutic efficacy of metformin can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Articaine.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with malathion.


The therapeutic efficacy of indapamide can be decreased when used in combination with celecoxib.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with salicylamide.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Nabilone can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of mefloquine can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of metolazone can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Dienogest.


The therapeutic efficacy of Miglustat can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with THYMOL.


The therapeutic efficacy of estramustine can be decreased when used in combination with METHOHEXITAL.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with epirizole.


The therapeutic efficacy of metformin can be decreased when used in combination with Fosamprenavir.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with chloroquine.


The therapeutic efficacy of azlocillin can be decreased when used in combination with minocycline.


The therapeutic efficacy of amoxicillin can be decreased when used in combination with minocycline.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with salicylamide.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with risperidone.


The therapeutic efficacy of Travoprost can be decreased when used in combination with alclofenac.


The therapeutic efficacy of glipizide can be decreased when used in combination with prednisone.


The therapeutic efficacy of dicumarol can be decreased when used in combination with progesterone.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with primidone.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with decamethonium.


The therapeutic efficacy of metformin can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Naftifine.


The therapeutic efficacy of warfarin can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of azlocillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of amoxicillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of nateglinide can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of Ximelagatran can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of Miglustat can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of gabapentin can be decreased when used in combination with mefloquine.


The therapeutic efficacy of pancuronium can be decreased when used in combination with donepezil.


The therapeutic efficacy of Travoprost can be decreased when used in combination with Apremilast.


The therapeutic efficacy of PIPECURONIUM can be decreased when used in combination with donepezil.


The therapeutic efficacy of brimonidine can be decreased when used in combination with mianserin.


The therapeutic efficacy of prochlorperazine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of misoprostol can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with etodolac.


The therapeutic efficacy of labetalol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of AMILORIDE can be decreased when used in combination with acemetacin.


The therapeutic efficacy of doxazosin can be decreased when used in combination with acemetacin.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of estramustine can be decreased when used in combination with thiamylal.


The therapeutic efficacy of glimepiride can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with thiopental.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of tolazamide can be decreased when used in combination with quetiapine.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with alclofenac.


The therapeutic efficacy of latanoprost can be decreased when used in combination with sulindac.


The therapeutic efficacy of glipizide can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of misoprostol can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of mesalamine can be decreased when used in combination with dexlansoprazole.


The therapeutic efficacy of glipizide can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with Asenapine.


The therapeutic efficacy of Limaprost can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of pentazocine can be decreased when used in combination with naltrexone.


The therapeutic efficacy of phenindione can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of PENICILLIN G PROCAINE can be decreased when used in combination with oxytetracycline.


The therapeutic efficacy of Bismuth subcitrate potassium can be decreased when used in combination with Magaldrate.


The therapeutic efficacy of trifluoperazine can be decreased when used in combination with levodopa.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with fluconazole.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with chloroquine.


The therapeutic efficacy of misoprostol can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of metolazone can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of ethosuximide can be decreased when used in combination with PSEUDOEPHEDRINE.


The therapeutic efficacy of nitrazepam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Droxicam.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of progesterone can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Octreotide.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of Tramadol can be decreased when used in combination with Cinacalcet.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with equilin.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Risedronic acid can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of gliclazide can be decreased when used in combination with norethindrone.


The therapeutic efficacy of ipratropium can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with Fluticasone furoate.


The therapeutic efficacy of gemeprost can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of Trospium can be decreased when used in combination with memantine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with azelastine.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cefdinir.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with nabumetone.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with resveratrol.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with PREDNICARBATE.


The therapeutic efficacy of eperisone can be decreased when used in combination with mefloquine.


The therapeutic efficacy of acarbose can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with nystatin.


The therapeutic efficacy of Miglustat can be decreased when used in combination with bumetanide.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with bumetanide.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Icatibant.


The therapeutic efficacy of Pregabalin can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Saxagliptin.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with Alitretinoin.


The therapeutic efficacy of folic acid can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of Travoprost can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with Estrone sulfate.


The therapeutic efficacy of penicillin v can be decreased when used in combination with minocycline.


The therapeutic efficacy of Metixene can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of metformin can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with piperazine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Pipotiazine.


The therapeutic efficacy of estazolam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Darunavir.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with memantine.


The therapeutic efficacy of misoprostol can be decreased when used in combination with aspirin.